compounding tirzepatide update FDA Allows Compounded During Shortage Review Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

Kerry Rafferty, who started charity Melanoma-Me after her own diagnosis, described the products as "skin cancer in a bottle"

New app features include Medication Tracking with Side Effect Support, Welli Meal Planner, and AI-driven Dynamic Calorie Goals based on body-scan technology

The most clinically significant cause is hypoglycaemia (low blood glucose), particularly in patients who are also taking other glucose-lowering medications such as sulphonylureas or insulin

Cardiovascular benefits: Beyond glucose and weight effects, early research shows tirzepatide may reduce major cardiovascular events by 14% and hospitalizations by 30%